 Here, the authors characterize a SARS-CoV-2 subunit vaccine candidate that contains four-length spike protein stabilised in its pre-fusion confirmation and show immunogenicity in baboons and protection in mice with matrix M adjuvant vaccine. This article was authored by Jinghui Chen, Nita Patel, Robert Horped, and others.